[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@RaasGroup RaaS Group
RaaS Group posts on X about stocks, $sgllv, $btl, $art the most. They currently have XXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX +8.60%
- X Month XXXXX -XX%
- X Months XXXXXX +117%
- X Year XXXXXX +126%
Mentions: X #
- X Week X -XX%
- X Month XX -XX%
- X Months XX +21%
- X Year XXX +131%
Followers: XXX #
- X Week XXX +0.32%
- X Month XXX +7.50%
- X Months XXX +79%
- X Year XXX +45%
CreatorRank: undefined #
Social Influence #
Social category influence cryptocurrencies XXXX% finance XXXX% stocks XXXX%
Social topic influence stocks 3.13%, $sgllv 3.13%, $btl 3.13%, $art 3.13%, $kyp 3.13%, $hrz 3.13%, $wa8 3.13%, $wrk 3.13%, asx 3.13%, $aya XXXX%
Top accounts mentioned or mentioned by @cmicrocaps @finolaburke3 @joinyellowbrick @provarisenergy @readcloud @warriedarres @empireenergyasx @airtasker @horizonhrz @pureprofileir @dznbkr @asx @fluencecorp @dznbkrs @noosamining @catapultsports @artrya1 @the_scanner_man @shivamkashan @rothetob
Top assets mentioned Battle Saga (BTL) Westrock Co (WRK) Aryacoin (AYA)
Top Social Posts #
Top posts by engagements in the last XX hours
"A big call out to the 22+ companies covered by @RaasGroup for ending August collectively up XX% more than double the XX% increase in the ASX Emerging Companies Index. An extraordinary XX% of our stocks under coverage ended the month higher Big gains from $SGLLV $BTL $ART $KYP $HRZ $WA8 and $WRK"
X Link @RaasGroup 2025-08-31T07:47Z XXX followers, 1584 engagements
"@RaasGroup has published a new RaaS+ report on medical software group @Artrya1 $AYA. This report is for subscribers to RaaS+ only. To subscribe go to and click through to the subscribe/logon page. Our senior analyst Naheed Rahman CFA is of the view that while revenue generation is in its early stages AYA has the FDA approvals and reimbursements in place to benefit over the course of the next two to three years. On our Ratios and Profitability metrics for lifesciences companies AYA scores X out of X. This is a report not to miss. Subscribe now just $1200 per year ex GST and get at least 52"
X Link @RaasGroup 2025-10-15T01:33Z XXX followers, XXX engagements